Rosa and FOCUS-IP Form Strategic Alliance for Enhancing Proof-of-Concept Drug Development

The Rosa-FOCUS-IP alliance will strengthen FOCUS-IP’s innovative exploratory development programs and candidate licensing evaluations with the systematic use of Rosa’s best-in-class in silico drug-disease modeling & simulation capabilities. (Press Release).